Roche Receives CE Mark for PCR Test Targeting Bacterial Vaginosis and Candida Vaginitis
The cobas BV/CV assay aims to improve diagnostic accuracy over traditional microscopy and pH testing methods for symptomatic patients.
The cobas BV/CV assay aims to improve diagnostic accuracy over traditional microscopy and pH testing methods for symptomatic patients.
Dotz Nano will introduce its Mega-Diagnostic Platform for en masse, rapid diagnosis of COVID-19 at the point of care.
The SARS-CoV-2 Rapid Antigen Test Nasal collects the sample from the front area of the nose instead of the nasopharynx, and can be self-collected.
The assay received CE-IVD marking for the use of saliva as specimen type and the option to pool up to five specimens collected from individuals suspected of covid-19 or asymptomatic individuals.
Read MoreThe Ortho Optix Reader’s high-resolution camera captures color, grayscale, front and back images of each test without operator intervention.
Read MoreThe SARS-CoV-2 IgG Antibody Test (sCOVG) is an enhanced version of the assay which became available globally this summer.
Read MoreThe PKamp Respiratory SARS-CoV-2 RT-PCR Panel enables differential diagnosis between covid-19, flu, and RSV infections.
Read MoreCompared to PCR, Ortho’s test may be better able to identify individuals with covid-19 who are infectious because the test is offered with 100% sensitivity.
Read MoreThe PrecisionOne system functions as a metabolic autopilot, providing automated glucose regulation and real-time analysis of blood chemistry values for critical care patients.
Read MoreSeptiCyte Rapid distinguishes sepsis from non-infectious systemic inflammation in patients suspected of sepsis and provides actionable results in about 1 hour.
Read MoreThe new BD covid-19 antigen test delivers results in 15 minutes on the portable BD Veritor Plus System.
Read MoreRoche will launch a covid-19 Rapid Antigen Test in late September for markets accepting the CE Mark.
Read MoreThis kit features a limit of detection as low as 15 GEC per reaction and includes ready-to-use reaction mixtures to reduce hands-on time.
Read MoreThe Signatera test is a personalized, tumor-informed ctDNA assay optimized for molecular residual disease assessment and treatment monitoring.
Read MoreThe NeuMoDx TV/MG assay implemented on the NeuMoDx Molecular system allows for automated detection of T. vaginalis and M. genitalium simultaneously.
Read MoreThe app will enable broader access to therapy-relevant information for non-insulin-dependent people with type 2 diabetes or prediabetes.
Read MoreDisqver uses next-generation sequencing of cell-free DNA to detect more than 1,500 bacteria, DNA viruses, fungi, and parasites in a patient’s bloodstream.
Read MoreThe assay is intended to help stop the spread and transmission of carbapenem-producing organisms.
Read More